Impact of dual anti-HER2 therapy on pathologic complete response rate in breast cancer in a minority-enriched population.

Jenny Jing Li,Hsiao Ching Li,Ang Gao,Samira Syed,Nisha Unni,Navid Sadeghi

Impact of dual anti-HER2 therapy on pathologic complete response rate in breast cancer in a minority-enriched population.

2019

Jenny Jing Li
Hsiao Ching Li
Ang Gao
Samira Syed
Nisha Unni
Navid Sadeghi

e18111Background: The addition of pertuzumab (P) to a neoadjuvant trastuzumab (H) plus chemotherapy combination has been shown to significantly improve the pathologic complete response rate (pCR) i...

Keywords:

Population
Breast cancer
Response rate (survey)
Oncology
Pathology
Internal medicine
Medicine
complete response
anti her2
Pertuzumab
Trastuzumab
Chemotherapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations